Ticlopidine

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Antiplatelets.

Half-lifeThis section has been translated automatically.

30–50 h

IndicationThis section has been translated automatically.

Prophylaxis of arterial and venous thromboses, arterial occlusive disease of the peripheral type.

Limited indicationThis section has been translated automatically.

Severe liver dysfunction.

Dosage and method of useThis section has been translated automatically.

1-3 times/day 250 mg p.o.

Remember! Ticlopidine should not be administered to patients with increased bleeding tendency or gastrointestinal ulcers. The preparation should be discontinued 1 week before planned operations. In emergencies the effect of Ticlopidine can be reversed by a single administration of 20 mg methylprednisolone. Before the start of therapy and during the first 3 months of treatment, a differential BB and platelet count is required at 14-day intervals!

Undesirable effectsThis section has been translated automatically.

Nausea, abdominal pain, diarrhea, allergic reactions, BB changes, jaundice with hepatitis and cholestasis, headache and dizziness.

InteractionsThis section has been translated automatically.

See Table 1.

ContraindicationThis section has been translated automatically.

Pregnancy, lactation, agranulocytosis, bleeding tendency also in the medical history, chronic inflammatory bowel diseases, children and adolescents < 16 years, leukopenia, gastrointestinal ulcers, neutropenia, operations, acute hemorrhagic apoplexy, thrombopenia.

PreparationsThis section has been translated automatically.

Tiklyd

PatientinformationThis section has been translated automatically.

Remember! The patient should consult the doctor immediately if ulcers appear in the mouth and throat area, tonsillitis and fever. Ticlopidine should be taken after meals to reduce the gastrointestinal side effects!

TablesThis section has been translated automatically.

Significant interactions of ticlopidine

Antirheumatic drugs, non-steroidal

Bleeding tendency ↑

Cephalosporins

Bleeding tendency ↑

Cimetidine

Ticlopidine levels ↑

Clozapine

Agranulocytosis, avoid combination

Coumarins

Bleeding tendency ↑

Dihydroergotamine

Bleeding tendency ↑

Penicillin i.v.

Bleeding tendency ↑

Theophyllins

Theophylline levels ↑

Platelet concentrates

Ticlopidine effect ↓

Authors

Last updated on: 29.10.2020